Investing.com -- Piper Sandler initiated coverage of Figma with an Overweight rating and an $85 price target, saying the design software firm is a long-term growth story with a differentiated platform ...

Investing.com -- Boston Dynamics and Toyota (NYSE: TM) Research Institute (TRI) have demonstrated a significant advancement ...

Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...

LUXEMBOURG - Corporación América Airports S.A. (NYSE: CAAP) reported second-quarter revenue that exceeded analyst expectations, driven by strong passenger traffic growth across its airport network, ...